American Journal of Ophthalmology · 2024 · 12 citations · 31 references
MedicineOphthalmologyPharmacologyClinical PharmacologyDiabetologyOcular PharmacologyDiabetes MellitusDiabetes PreventionGlaucomaGlycemic ControlSodium-glucose Cotransporter 2 InhibitorsAnti-glaucoma PharmacotherapyAntiglaucoma TherapyEmulationSodium-glucose CotransportSodium-glucose Cotransporter 2 InhibitionType 2 Diabetes Mellitus TreatmentType 2 Diabetes Treatment
31
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 12K citations · Full text
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Vlado Perkovic, Meg Jardine, Bruce Neal et al. · New England Journal of Medicine · 2019 · 6K citations · Full text
Medicine, Nephrology, Pharmacology +17
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer, Stefan D. Anker, Javed Butler et al. · New England Journal of Medicine · 2020 · 5K citations · Full text
Medicine, Cardiology, Pharmacology +17
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Stefan D. Anker, Javed Butler, Gerasimos Filippatos et al. · New England Journal of Medicine · 2021 · 4.6K citations · Full text
Medicine, Cardiology, Pharmacology +14
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner, Silvio E. Inzucchi, John M. Lachin et al. · New England Journal of Medicine · 2016 · 3.6K citations · Full text